Literature DB >> 20466563

Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel.

Haibin Wang1, Xuelian Zhang, Yanmin Li, Yitong Ma, Ye Zhang, Zhiqiang Liu, Jin Zhou, Qiuxia Lin, Yanmeng Wang, Cuimi Duan, Changyong Wang.   

Abstract

BACKGROUND: Basic fibroblast growth factor (bFGF) stimulates neoangiogenesis. The sustained release of bFGF by using biomaterials helped to enhance its angiogenic activity in vivo. In this study we investigated the effects of co-injection of bFGF with temperature-responsive chitosan hydrogel on myocardial performance in a rat model of infarction.
METHODS: Myocardial infarction was induced in rats using coronary artery ligation. Temperature-responsive chitosan hydrogel was prepared and injected intramyocardially into the left ventricular wall of rat infarction models alone or together with bFGF. Detailed histologic analysis and echocardiography were used to determine the structural and functional consequences 4 weeks after injection.
RESULTS: Heart function improved significantly in the chitosan+bFGF group compared with the phosphate-buffered saline (PBS)+bFGF group with regard to left ventricular ejection fraction (LVEF) and LV fractional shortening (LVFS) 4 weeks after transplantation (p < 0.05, n = 8 per group). In addition, arteriole densities within the infarcted area improved significantly (p < 0.01) in the chitosan+bFGF group (259 +/- 22/mm(2)) compared with the PBS+bFGF group (95 +/- 18/mm(2); n = 8 per group) at 4 weeks after transplantation. Infarct size and fibrotic area decreased significantly (p < 0.05) in the chitosan+bFGF group (39.64 +/- 1.75% and 25.09 +/- 3.31%, respectively) compared with the PBS+bFGF group (48.91 +/- 1.39% and 48.0 +/- 3.83%, respectively; n = 8 per group). No significant difference (p > 0.05) was noted between the PBS and PBS+bFGF groups.
CONCLUSIONS: Co-injection of bFGF with temperature-responsive chitosan hydrogels enhanced the effects of bFGF on arteriogenesis, ventricular remodeling and cardiac function. Our findings suggest a new approach to improve infarcted repairs in the prevention of adverse remodeling after myocardial infarction. Copyright (c) 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466563     DOI: 10.1016/j.healun.2010.03.016

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  34 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium.

Authors:  Jessica C Garbern; Elina Minami; Patrick S Stayton; Charles E Murry
Journal:  Biomaterials       Date:  2010-12-24       Impact factor: 12.479

Review 3.  Injectable acellular hydrogels for cardiac repair.

Authors:  Elena Tous; Brendan Purcell; Jamie L Ifkovits; Jason A Burdick
Journal:  J Cardiovasc Transl Res       Date:  2011-06-28       Impact factor: 4.132

Review 4.  Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery.

Authors:  Laura Iop; Tiziana Palmosi; Eleonora Dal Sasso; Gino Gerosa
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

5.  Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injury.

Authors:  Swathi Ravi; Jeffrey M Caves; Adam W Martinez; Jiantao Xiao; Jing Wen; Carolyn A Haller; Michael E Davis; Elliot L Chaikof
Journal:  Biomaterials       Date:  2012-07-21       Impact factor: 12.479

Review 6.  New strategies for improving stem cell therapy in ischemic heart disease.

Authors:  Peisen Huang; Xiaqiu Tian; Qing Li; Yuejin Yang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 7.  Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?

Authors:  Maribella Domenech; Lilliana Polo-Corrales; Jaime E Ramirez-Vick; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2016-07-21       Impact factor: 6.389

Review 8.  The role of tissue engineering and biomaterials in cardiac regenerative medicine.

Authors:  Yimu Zhao; Nicole T Feric; Nimalan Thavandiran; Sara S Nunes; Milica Radisic
Journal:  Can J Cardiol       Date:  2014-09-04       Impact factor: 5.223

Review 9.  Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences.

Authors:  Yang Zhu; Yasumoto Matsumura; William R Wagner
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

10.  Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction.

Authors:  Tomo Yoshizumi; Yang Zhu; Hongbin Jiang; Antonio D'Amore; Hirokazu Sakaguchi; Jason Tchao; Kimimasa Tobita; William R Wagner
Journal:  Biomaterials       Date:  2015-12-15       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.